体外受精(IVF)のドイツ市場:サイクルタイプ別、エンドユーザー別

◆英語タイトル:Germany In Vitro Fertilization (IVF) Market by Cycle Type (Fresh IVF Cycles and Thawed IVF Cycles) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Opportunity Analysis and Industry Forecast, 2019–2026
◆商品コード:AMR9NV112
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2019年8月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:ドイツ
◆販売価格オプション(消費税別)
Single UserUSD2,850 ⇒換算¥307,800見積依頼/購入/質問フォーム
5 UserUSD3,423 ⇒換算¥369,684見積依頼/購入/質問フォーム
Enterprise UserUSD4,774 ⇒換算¥515,592見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

The Germany IVF market was valued at $398 million in 2018 and is estimated to reach $541 million by 2026, registering a CAGR of 3.9% during the analysis period.
In vitro fertilization (IVF) is a process that includes fertilization of egg cells outside the body. It is one of the widely known infertility treatment across the clinical industry. The technique is based on assisted reproductive technology and is employed in the treatment of infertility. The process involves removing an ovum (egg or eggs) the ovaries and facilitating its fertilization with the help of a sperm in a laboratory dish. After the fertilized egg (zygote) undergoes embryo culture for up to 6 days, it is implanted in another or same woman’s uterus, depending on the conditions. IVF helps achieve pregnancy when other treatments fail. It is generally not used until less expensive or invasive options have failed or been determined unlikely to work.

Subsidizing IVF treatments, delayed marriages and parenthood decisions, and increase in prevalence of infertility issues are the factors that majorly drive the growth of the IVF market in Germany. In addition, as per National Health Plan (NHP), about 50% of the treatment cost by IVF paid for three cycles is projected to boost growth of the IVF market in Germany. However, stringent government regulations and lack of availability in treatment cycles for IVF are the major restraints that hamper the growth of the market in Germany.

The Germany in vitro fertilization market (IVF) is segmented based on cycle type and end user. Based on cycle type, the market is divided into fresh IVF cycles (non-donor), and thawed IVF cycles (non-donor). Based on end user, the market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes.

KEY MARKET BENEFITS
• The study provides an in-depth analysis of the Germany in vitro fertilization (IVF) market along with the current trends and future estimations to elucidate the imminent investment pockets.
• The report presents a quantitative analysis of the market from 2018 to 2026 to enable stakeholders to capitalize on the prevailing market opportunities.
• An extensive analysis of the market based on application assists in understanding the trends in the industry.
• The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS
Germany In Vitro Fertilization Market
By Cycle Type
o Fresh IVF Cycles (Non-donor)
o Thawed IVF Cycles (Non-donor)
By End User
o Fertility Clinics
o Hospitals
o Surgical Centers
o Clinical Research Institutes

LIST of KEY PLAYERS PRofILED IN THE REPORT
• Heidelberg University Hospital
• Klinikum Stuttgart
• DRK Kliniken Berlin
• University Medical Center Freiburg

【レポートの目次】

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

Chapter 4: Germany In Vitro Fertilization (Ivf) Market

4.1. Overview
4.2. Germany Ivf Market By Cycle Type

4.2.1. Fresh Ivf Cycles (Non-Donor)
4.2.2. Thawed Ivf Cycles (Non-Donor)

4.3. Number of Infertility Clinics, 2018
4.4. Germany Ivf Market By End Users

4.4.1. Fertility Clinics
4.4.2. Hospitals
4.4.3. Surgical Centers
4.4.4. Clinical Research Institutes

4.5. Market Drivers

4.5.1. Drivers

4.5.1.1. Subsidizing Ivf Treatments
4.5.1.2. Delayed Marriages And Parenthood Decisions

4.5.2. Restraints

4.5.2.1. Stringent Government Regulations
4.5.2.2. Lack of Availability In Treatment Cycles For Ivf

4.5.3. Regulatory Issues, Legislations, And Authorities
4.5.4. Insurance Reimbursement Scenario

4.6. Company Profiles – Germany

4.6.1. Heidelberg University Hospital

4.6.1.1. Company Overview

4.6.2. Klinikum Stuttgart

4.6.2.1. Company Overview

4.6.3. Drk Kliniken Berlin

4.6.3.1. Company Overview

4.6.4. University Medical Center Freiburg

4.6.4.1. Company Overview

4.6.5. Praxis Fur Fertilitat

4.6.5.1. Company Overview

4.6.6. Vivaneo Deutschland Gmbh

4.6.6.1. Company Overview

List of Tables

Table 01. Germany Ivf Market, Volume And Value, 2018–2026 (Thousand And $Million)
Table 02. Germany Ivf Market, By Cycle Type, 2018-2026 ($Million)
Table 03. Germany Ivf Market, By Cycle Type, 2018-2026 (Thousand)
Table 04. Germany Ivf Market, By End Users, 2018–2026 (Million)
Table 05. Germany Ivf Market, By End Users, 2018–2026 (Thousand)
Table 06. Heidelberg University Hospital Business Overview
Table 07. Snapshot of Heidelberg University Hospital
Table 08. Klinikum Stuttgart Business Overview
Table 09. Snapshot of Klinikum Stuttgart
Table 10. Drk Kliniken Berlin Business Overview
Table 11. Snapshot of Drk Kliniken Berlin
Table 12. University Medical Center Freiburg Business Overview
Table 13. Snapshot of University Medical Center Freiburg
Table 14. Praxis Fur Fertilitat Business Overview
Table 15. Praxis Fur Fertilitat
Table 16. Vivaneo Deutschland Gmbh Business Overview
Table 17. Vivaneo Deutschland Gmbh

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[体外受精(IVF)のドイツ市場:サイクルタイプ別、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆